| Completed | Neurocircuit Strategy to Decrease Cocaine Cue Reactivity NCT04155632 | Medical University of South Carolina | Phase 2 |
| Unknown | Benefits of Therapy With Virtual Reality Exposure in the Treatment of Cocaine Use Disorders NCT04280900 | University Hospital, Clermont-Ferrand | N/A |
| Completed | The Role of Neuroactive Steroids in Stress, Drug Craving and Drug Use in Cocaine Use Disorders NCT03953612 | Yale University | EARLY_Phase 1 |
| Completed | Open Label Pharmaco- Magnetic Resonance Spectrography (MRS) Study of Clavulanic Acid NCT03986762 | Temple University | Phase 1 |
| Unknown | Use of Intranasal Oxytocin During Detoxification of Crack Cocaine NCT04306354 | Pontificia Universidade Católica do Rio Grande do Sul | Phase 1 / Phase 2 |
| Unknown | Computerized Exercise to Alter Stimulant Approach Responses NCT03902405 | University of British Columbia | N/A |
| Completed | Evaluation of N-Acetylcysteine Efficacy to Reduce the Craving and to Prolong Abstinence Time of Coca Paste NCT03556371 | University of Concepcion, Chile | Phase 2 |
| Completed | Brain Mechanisms in Young Adults NCT03606473 | Gale Richardson | EARLY_Phase 1 |
| Completed | Lorcaserin in the Treatment of Cocaine Use Disorder NCT03007394 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Unknown | Transcranial Magnetic Stimulation for Cocaine Addiction NCT03333460 | ITAB - Institute for Advanced Biomedical Technologies | N/A |
| Unknown | Treatment With Transcranial Magnetic Stimulation for Cocaine Addiction: Clinical Response and Functional Conne NCT02986438 | Instituto Nacional de Psiquiatría Dr. Ramón de la Fuente | N/A |
| Completed | Targeting Anhedonia in Cocaine Use Disorder NCT02773212 | University of Illinois at Chicago | Phase 2 |
| Completed | Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention NCT02896712 | The University of Texas Health Science Center, Houston | Phase 2 |
| Completed | Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study NCT02563769 | Temple University | Phase 1 |
| Completed | Conflict Between Maternal Autonomy and Child Health in Substance-use NCT02797990 | London School of Hygiene and Tropical Medicine | — |
| Completed | Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network NCT02915341 | Dartmouth-Hitchcock Medical Center | — |
| Terminated | Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disor NCT03143543 | Virginia Commonwealth University | Phase 1 |
| Completed | Psilocybin-facilitated Treatment for Cocaine Use NCT02037126 | University of Alabama at Birmingham | Phase 2 |
| Completed | Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence NCT01984177 | Centre for Addiction and Mental Health | — |
| Completed | Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin NCT01723527 | Johns Hopkins University | Phase 1 |
| Completed | Contingency Management Treatment for Crack Addiction - Study With Brazilian Population NCT01815645 | Federal University of São Paulo | N/A |
| Completed | Improving Learning-based Treatment of Cocaine Dependence With Medication NCT01526538 | Johns Hopkins University | Phase 2 |
| Completed | Effects of N-acetylcysteine on Brain Chemistry and Behavior in Cocaine Abusers (NAC) NCT01392092 | Wayne State University | — |
| Completed | Brain Imaging of Cocaine Craving in Recreational Cocaine Users NCT01189578 | James J. Prisciandaro | — |
| Terminated | Interactions Between Intravenous (IV) Cocaine and Lofexidine NCT01148992 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Non-Treatment Study of Factors Affecting Cocaine Drug Choice NCT00946660 | Wayne State University | — |
| Completed | Prize Reinforcement Contingency Management for Cocaine Dependence: a 24-week Randomized Controlled Trial NCT00877435 | University Hospital, Basel, Switzerland | N/A |
| Completed | Buprenorphine Naltrexone-P1 A-Cocaine NCT00733720 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients NCT00780702 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Stress and Medication Effects on Cocaine Cue Reactivity NCT00613015 | Medical University of South Carolina | Phase 2 |
| Completed | The Effect of Yohimbine on Cocaine Cue Reactivity NCT00535002 | Medical University of South Carolina | Phase 2 |
| Terminated | Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-deficit Hyperact NCT00514202 | The University of Texas Health Science Center, Houston | Phase 2 |
| Suspended | The Effects of Pharmacotherapy on Brain Mechanisms Underlying Cocaine Dependence. NCT00396734 | Hadassah Medical Organization | N/A |
| Completed | Topiramate to Reduce Cocaine Dependence NCT00223626 | Bankole Johnson | Phase 2 |
| Completed | Acoustic Startle Reduction In Cocaine Dependence NCT00430690 | Emory University | — |
| Completed | Medications for Stopping Cocaine Dependence and Preventing Relapse NCT00218023 | The University of Texas Health Science Center, Houston | Phase 2 |
| Completed | Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals NCT00218062 | The University of Texas Health Science Center, Houston | Phase 2 |
| Completed | Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence NCT00142818 | Kyle Kampman | Phase 2 |
| Completed | Aripiprazole to Reduce Cocaine Relapse NCT00276874 | Craig Rush | Phase 1 |
| Completed | Employment-based Reinforcement of Naltrexone Ingestion and Abstinence NCT00149669 | Johns Hopkins University | N/A |
| Unknown | Effectiveness of Topiramate in Treating Cocaine Dependent Individuals - 1 NCT00249691 | Bankole Johnson | Phase 3 |
| Completed | Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals NCT00217997 | The University of Texas Health Science Center, Houston | — |
| Completed | Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1 NCT00265265 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Efficacy of Caffeine, With and Without Biperiden, in the Detoxification of Cocaine Dependent Patients NCT00495092 | Hospital Universitari Vall d'Hebron Research Institute | Phase 2 / Phase 3 |
| Terminated | Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals NCT00218049 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1 NCT00129298 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Modafinil for the Treatment of Cocaine Dependence - 1 NCT00100100 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Terminated | The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3 NCT00142883 | Yale University | N/A |
| Unknown | Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1 NCT00094315 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Unknown | Interactions Between Cocaine and Ethanol and Disulfiram - 1 NCT00094289 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Modafinil Treatment for Cocaine-Dependent Individuals NCT00129285 | University of Pennsylvania | Phase 2 |
| Completed | Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD) NCT00218543 | New York State Psychiatric Institute | Phase 2 |
| Unknown | Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1 NCT00100113 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Baclofen for the Treatment of Cocaine Dependence - 1 NCT00082485 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Unknown | GBR 12909 Study in Cocaine Experienced African American Volunteers - 1 NCT00089687 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management NCT00292110 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11 NCT00015301 | National Institute on Drug Abuse (NIDA) | Phase 4 |
| Completed | Quetiapine for Cocaine Use and Cravings NCT00232336 | Seattle Institute for Biomedical and Clinical Research | Phase 4 |
| Unknown | Interaction Between Cocaine and Quetiapine - 1 NCT00087750 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo NCT00218348 | The University of Texas Health Science Center, Houston | Phase 2 |
| Completed | Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1 NCT00067535 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | The Therapeutic Workplace Initiation Study NCT00249470 | Johns Hopkins University | N/A |
| Completed | Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4 NCT00000307 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1 NCT00136825 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2 NCT00134901 | New York State Psychiatric Institute | Phase 2 |
| Completed | Cocaethylene as a Treatment for Cocaine Dependence - 1 NCT00124696 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Tiagabine for the Treatment of Cocaine Dependence - 1 NCT00086255 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Unknown | Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1 NCT00051896 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Progesterone for the Treatment of Cocaine Dependence - 1 NCT00218257 | University of Minnesota | N/A |
| Unknown | Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1 NCT00040066 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Unknown | Cocaine-Metyrapone Interaction Study - 1 NCT00033098 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Effectiveness of GABA Agonists in Reducing the Reinforcing Effects of Cocaine NCT00218166 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Unknown | Assessment of Potential Interactions Between Cocaine and Tolcapone - 1 NCT00033059 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Reserpine for the Treatment of Cocaine Dependence - 1 NCT00033033 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | A Study of Cabergoline for the Treatment of Cocaine Dependence - 1 NCT00033111 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Unknown | Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1 NCT00033046 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Unknown | Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1 NCT00032916 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Evaluation of Benztropine for Cocaine Craving - 2 NCT00000333 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Ondansetron for the Treatment of Cocaine Dependence - 1 NCT00033085 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts NCT00142779 | National Institute on Drug Abuse (NIDA) | N/A |
| Completed | Disulfiram for Treating Cocaine Dependence in Individuals Maintained on Methadone NCT00218608 | University of Arkansas | Phase 2 |
| Completed | Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1 NCT00032929 | National Institute on Drug Abuse (NIDA) | Phase 3 |
| Completed | Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence NCT00218075 | The University of Texas Health Science Center, Houston | Phase 2 |
| Completed | Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals NCT00249483 | New York State Psychiatric Institute | Phase 2 |
| Completed | Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2 NCT00158132 | University of Pennsylvania | Phase 2 |
| Completed | Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1 NCT00142844 | University of Pennsylvania | Phase 2 |
| Completed | Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocain NCT00000240 | University of Vermont | Phase 2 |
| Completed | Tiagabine, Sertraline, or Donepezil for the Treatment of Cocaine Dependence - 9 NCT00015132 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10 NCT00000293 | National Institute on Drug Abuse (NIDA) | Phase 3 |
| Completed | Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3 NCT00015054 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Effects of Carvedilol on Cocaine Use in Humans - 11 NCT00000294 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | High Dose Nimodipine Treatment Adjunct - 1 NCT00000332 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Methylphenidate Treatment for Cocaine Abuse and ADHD - 1 NCT00136734 | New York State Psychiatric Institute | Phase 1 |
| Completed | Cocaine-Methylphendidate Interaction Study - 4 NCT00015067 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Resperine, Gabapentin, or Lamotrigine for the Treatment of Cocaine Dependence: 2 - 7 NCT00015106 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6 NCT00000303 | University of California, Los Angeles | Phase 2 |
| Completed | Effects of Labetalol on Human Cocaine Use - 8 NCT00000291 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Dextroamphetamine as an Adjunct in Cocaine Treatment - 1 NCT00000304 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Risperidone for Treatment of Cocaine Dependence in Outpatients - 12 NCT00000347 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Diso NCT00015223 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Stress Hormones and Human Cocaine Use - 7 NCT00000290 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Modeling Impaired Judgement in Cocaine Abusers - 6 NCT00015236 | National Institute on Drug Abuse (NIDA) | Phase 4 |
| Completed | Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9 NCT00000274 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Tryptophan and Behavior Therapy for Cocaine Abuse - 1 NCT00000324 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Prepulse Inhibition of Startle in Cocaine Dependence - 7 NCT00015249 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Nefazodone in the Treatment of Cocaine Dependence and Depression - 4 NCT00015210 | Boston Medical Center | Phase 2 |
| Completed | Cocaine Effects in Humans: Physiology and Behavior - 1 NCT00000200 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3 NCT00000286 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Cocaine Abuse and ADHD - 10 NCT00000275 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1 NCT00000315 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Piracetam for Treatment of Cocaine Addiction - 3 NCT00000198 | University of Pennsylvania | Phase 1 |
| Completed | Early Phase II Trials for Cocaine Medication Development - 1 NCT00000317 | New York State Psychiatric Institute | Phase 2 |
| Completed | Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2 NCT00000316 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Risperidone for the Treatment of Cocaine Dependence - 7 NCT00000342 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Therapeutic Potential of Kappa-Opioids Against Cocaine - 1 NCT00000323 | National Institute on Drug Abuse (NIDA) | — |
| Withdrawn | Pemoline in the Treatment of Stimulant Dependence - 5 NCT00000340 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Unknown | Infusion Laboratory: Protocol 3 (Risperidone) - 4 NCT00000339 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Effects of Phenytoin on Cocaine Use in Humans - 2 NCT00000285 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Acute Withdrawal From Smoked Cocaine - 9 NCT00000292 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Unknown | Infusion Laboratory: Protocol 2 (Lisuride) - 3 NCT00000338 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4 NCT00000301 | University of California, Los Angeles | Phase 2 |
| Completed | Dose Response Trial of Pergolide for Cocaine Dependence - 1 NCT00000248 | Medical University of South Carolina | Phase 3 |
| Terminated | Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2 NCT00000310 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Withdrawn | Brain Imaging: Cocaine Effects & Medication Development - 5 NCT00000270 | New York State Psychiatric Institute | Phase 4 |
| Completed | Pergolide Treatment for Substance Abusers - 4 NCT00000269 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Dextroamphetamine-Cocaine Behavioral Intervention - 5 NCT00000308 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Naltrexone in Treatment of Cocaine Dependence - 5 NCT00015080 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Cocaine Abuse and Attention Deficit Disorder - 3 NCT00000268 | National Institute on Drug Abuse (NIDA) | N/A |
| Completed | Combining Behavioral Treatment With Agonist Maintenance - 1 NCT00000311 | Yale University | Phase 3 |
| Completed | Relapse Patterns in Female Cocaine Users - 4 NCT00000287 | National Institute on Drug Abuse (NIDA) | — |
| Completed | Selegiline in Outpatient Treatment for Cocaine Dependence - 1 NCT00000336 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | New Approaches to Cocaine Abuse Medications (A) - 6 NCT00000271 | New York State Psychiatric Institute | Phase 2 |
| Completed | Infusion Laboratory: Protocol 1 - Selegeline - 2 NCT00000337 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Pemoline for Cocaine Abuse - 7 NCT00000282 | Yale University | Phase 2 |
| Terminated | Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 NCT00000276 | Yale University | Phase 1 |
| Completed | Selegiline in Treatment of Cocaine Dependence - 2 NCT00000188 | University of Pennsylvania | Phase 2 |
| Completed | Disulfiram for Cocaine-Alcohol Abuse - 3 NCT00000278 | Yale University | Phase 2 |
| Completed | Mazindol for Cocaine Abuse - 2 NCT00000277 | Yale University | Phase 2 |
| Completed | Pharmacotherapy for Schizophrenic Drug Users - 6 NCT00000281 | Yale University | Phase 2 |
| Completed | Glutaminergic Agents for Cocaine Abuse - 5 NCT00000280 | Yale University | Phase 1 |
| Completed | M-CPP and Fenfluramine in Cocaine Addicts - 3 NCT00000314 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3 NCT00000306 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1 NCT00000266 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Terminated | Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1 NCT00000309 | Butler Hospital | Phase 2 |
| Completed | Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1 NCT00000245 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Carbamazepine Treatment of Cocaine Dependence - 1 NCT00000242 | Medical University of South Carolina | Phase 2 |
| Completed | Ritanserin in Treatment of Cocaine Dependence - 1 NCT00000187 | University of Pennsylvania | Phase 2 |
| Completed | IV Cocaine Abuse: A Laboratory Model - 3 NCT00000214 | New York State Psychiatric Institute | Phase 2 |
| Completed | Cocaine in Parotid Saliva, Blood and Urine - 4 NCT00000190 | University of Pennsylvania | Phase 1 |
| Completed | Carbamazepine Treatment for Cocaine Dependence - 5 NCT00000191 | University of Pennsylvania | Phase 2 |
| Completed | Pharmacotherapy and Intensive Treatment of Drug Abuse - 1 NCT00000217 | University of Kansas | Phase 2 |
| Completed | IV Cocaine Abuse: A Laboratory Model - 2 NCT00000213 | New York State Psychiatric Institute | Phase 2 |
| Completed | Gepirone vs Placebo in Treatment of Cocaine Dependence - 3 NCT00000189 | University of Pennsylvania | Phase 2 |
| Completed | Treatment Efficacy for Drug Abuse and AIDS Prevention - 1 NCT00000210 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Treatment Efficacy for Drug Abuse and AIDS Prevention - 2 NCT00000211 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | IV Cocaine Abuse: A Laboratory Model - 1 NCT00000212 | New York State Psychiatric Institute | Phase 2 |
| Completed | Propranolol for Treatment of Cocaine Addiction - 2 NCT00000197 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Pharmacological Modulation of Cocaine Effects - 1 NCT00000201 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Alterations in Serotonergic Functions in Cocaine Addicts - 1 NCT00000312 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Terminated | Amphetamine Cocaine Interaction Study - 2 NCT00000305 | The University of Texas Health Science Center, Houston | Phase 1 |
| Completed | Pharmacotherapy and Intensive Treatment - 2 NCT00000218 | National Institute on Drug Abuse (NIDA) | Phase 4 |
| Completed | Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1 NCT00000216 | Yale University | Phase 3 |
| Unknown | Infusion Laboratory: Protocol 5 (Flupenthixol) - 14 NCT00000349 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Withdrawn | Piracetam for Treatment of Cocaine Addiction, Phase II - 4 NCT00000199 | University of Pennsylvania | Phase 1 |
| Completed | Psychostimulant Abuse - Novel Treatment Approaches - 1 NCT00000325 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | IV Cocaine Abuse: A Laboratory Model - 4 NCT00000215 | National Institute on Drug Abuse (NIDA) | Phase 2 |
| Completed | Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9 NCT00015275 | National Institute on Drug Abuse (NIDA) | Phase 4 |
| Unknown | Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13 NCT00000348 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Terminated | Predictive Values of Serotonergic Alterations for Outcome - 2 NCT00000313 | National Institute on Drug Abuse (NIDA) | Phase 1 |
| Completed | Risperidone Treatment in Dually-Diagnosed Individuals - 2 NCT00000267 | National Institute on Drug Abuse (NIDA) | Phase 2 |